ASCO 2021 | PREVENT: preventive HIPEC in combination with perioperative FLOT for gastric cancer

Thorsten O. Goetze, MD, University Cancer Center Frankfurt, Frankfurt, Germany, talks on the Phase III PREVENT trial (NCT04447352), a trial-in-progress investigating preventive Hyperthermic IntraPEritoneal Chemoperfusion (HIPEC) in combination with perioperative FLOT (fluoruracil, leucovorin, oxaliplatin and docetaxel) versus FLOT alone for resectable diffuse-type gastric and gastroesophageal junction type II/III adenocarcinoma. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.